Resmed (RMD) Revenue (2009 - 2026)

Resmed's Revenue history runs 18 years deep, the most recent figure standing at $1.4 billion for Q1 2026.

• Quarterly Revenue rose 10.81% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.5 billion (up 10.28% YoY) and the FY2025 annual result came in at $5.1 billion, up 9.84% from the prior year.
• Revenue was $1.4 billion for Q1 2026 at Resmed, up from $1.4 billion in the prior quarter.
• Across five years, Revenue topped out at $1.4 billion in Q1 2026 and bottomed at $864.5 million in Q1 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue grew 4.41% — and 2023, when it climbed 29.2%.
• Resmed's Revenue stood at $1.0 billion in 2022, then increased by 12.48% to $1.2 billion in 2023, then rose by 10.26% to $1.3 billion in 2024, then rose by 10.98% to $1.4 billion in 2025, then advanced by 0.6% to $1.4 billion in 2026.
• Business Quant data shows RMD's Revenue at $1.4 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.3 billion in Q3 2025.